We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Are You Cleaning More to Stop the Omicron Variant?
The virus that causes COVID-19 mainly spreads in the air, so antibacterial wipes and other deep-cleaning methods for surfaces…
CSL Scientist Strikes a Pose in Australian Vogue
A glossy magazine feature spotlights four women who played key roles in Australia’s COVID-19 vaccine development, including C…
In a Word: "Armamentarium"
COVID-19 made this big word more common, so what does it mean?
The Spider Everyone Is Talking About
A funnel web “megaspider” recently made headlines in Australia and it just might save lives.
CEO Paul Perreault at the 2021 STAT Summit
Leaders in science convened to discuss the most pressing topics in biotech, medicine and policy at the 2021 STAT Summit.
Researching Future Pandemics and Cancer Mysteries
Two Australian scientists win fellowships each worth AUD $1.25 million to transform our response to pandemics and explore pot…
The Artist Behind the Nobel Prize Portraits
Niklas Elmehed has painted the distinctive portraits of Nobel Laureates since 2012. He recently captured the likeness of Emil…
It's Almost Nobel Prize Time
Learn more about Emil von Behring, winner of the first Nobel Prize for Medicine in 1901.
Doctoral Candidate Wins Our Innovation Challenge
Australian scientist Stefanie Buchholz presented her work in isolating immunoglobulins and other plasma-derived proteins.
Advice for Aspiring Scientists
As college students return to campus, we asked CSL scientists to offer their best advice.
The Promise of Big Data for Lung Disease Patients
The launch of an open-source repository of thousands of lung scans invites a new era of AI-assisted research into rare diseas…
CSL Launches Annual Scholarship Program
Thirty-seven students receive awards in the first year of a new program for employees and dependents.
Popular search terms:
Americas
Asia Pacific
Europe
